Skip to content

Clinical trials

Enterobacteriaceae Infections trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Enterobacteriaceae Infections Clear all

42 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20072
20081
20093
20121
20131
20141
20153
20161
20173
20184
20196
20214
20223
20231
20243
20251
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Unknown status8
Recruiting5
Not yet recruiting2
Withdrawn2
Active, not recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Fondation Hôpital Saint-Joseph2
Fondazione Policlinico Universitario Agostino Gemelli IRCCS2
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla2
Hospital Italiano de Buenos Aires2
PATH2
Rambam Health Care Campus2
University Hospital, Geneva2
University of Pittsburgh2
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)1
Ankara City Hospital Bilkent1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Enterobacteriaceae Infections42
Bacteremia7
Infections4
Bacterial Infections3
Cross Infection3
Sepsis3
Diarrhea2
Digestive System Diseases2
Dysentery, Bacillary2
Escherichia coli Infections2

Trials

Showing 51 to 42 of 42. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.